NCT06874803 Acupuncture and Moxibustion for Motor Symptoms in Early Parkinson's Disease
| NCT ID | NCT06874803 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jiani Wu |
| Condition | Parkinson's Disease (PD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-08-01 |
| Primary Completion | 2025-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-08-01 with a primary completion date of 2025-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates the clinical effect and safety of acupuncture combined with moxibustion in improving motor symptoms of early-stage Parkinson's Disease (PD) patients, by assessing the changes in UPDRS scores. It also explores objective factors affecting the acupuncture effect and investigates the functional MRI mechanisms of acupuncture in PD treatment.
Eligibility Criteria
Inclusion Criteria: Participants must meet all of the following criteria: 1\. Diagnosed with Parkinson's disease (PD) according to the 2016 Chinese 2. Diagnostic Criteria for Parkinson's Disease. 3\. Hoehn-Yahr stage \<3 (mild to moderate PD). 4. Age between 30 and 80 years (inclusive). 5. Signed informed consent indicating voluntary participation. Exclusion Criteria: Participants meeting any of the following criteria will be excluded: 1. Diagnosed with Parkinson-plus syndromes or other secondary parkinsonism. 2. Prior history of deep brain stimulation (DBS) surgery. 3. Severe cerebrovascular disease, brain trauma, or history of craniotomy. 4. Severe dementia or psychiatric disorders that prevent cooperation with study procedures. 5. Severe coagulation disorders. 6. Presence of severe systemic organ dysfunction (cardiac, pulmonary, hepatic, renal, endocrine, or metabolic disorders). 7. Pregnant or breastfeeding women. 8. History of allergic reaction to acupuncture or moxibustion. 9. Pr
Frequently Asked Questions
Who can join the NCT06874803 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 80 Years, studying Parkinson's Disease (PD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06874803 currently recruiting?
Yes, NCT06874803 is actively recruiting participants. Visit ClinicalTrials.gov or contact Jiani Wu to inquire about joining.
Where is the NCT06874803 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06874803 clinical trial?
NCT06874803 is sponsored by Jiani Wu. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.